Table 1 |
|||||
|
Genetics in fibromyalgia |
|||||
|
Reference |
Year of study |
Number of subjects |
Number of control |
Objective measure |
Findings |
|
|
|||||
|
Bondy and colleagues [5] |
1999 |
168 FMS |
115 |
5-HT2A, T102C polymorphism |
Different from control, but not significant for specific allele |
|
Gürsoy and colleagues [6] |
2001 |
58 FMS |
58 |
5-HT2A, T102C polymorphism |
Not significant |
|
Gürsoy and colleagues [7] |
2003 |
61 FMS |
61 |
COMT haplotype |
Over-representation of LL variant (low activity). Similar to migraine and TMD |
|
Offenbaecher and colleagues [8] |
1999 |
62 FMS |
110 |
5-HTT |
One positive for over-representative SS genotype, one negative study. Suggestion that any association might be related to comorbid psychology |
|
Gürsoy [9] |
2002 |
53 FMS |
60 mentally healthy |
5-HTT |
|
|
Yunus and colleagues [4] |
1999 |
40 multicase families |
HLA |
Linkage to HLA |
|
|
Buskila and colleagues [10] |
2004 |
Dopamine D4 receptor polymorphism |
Decrease in the frequency of the seven-repeat allele in exon III of the D4 receptor gene associated with fibromyalgia. Finding associated with low novelty-seeking personality |
||
|
|
|||||
|
COMT, catecholamine o-methyl transferase; FMS, fibromyalgia syndrome; 5-HT2A, serotonergic 5-hydroxytryptamine 2A receptor (T/T phenotype); 5-HTT, serotonin transporter; TMD, temporomandibular disorder. |
|||||
|
Dadabhoy et al. Arthritis Research & Therapy 2008 10:211 doi:10.1186/ar2443 |
|||||